• Content Hubs
    • Bupa
    • UnitedHealthcare Global
  • About
  • Alerts
  • Advertise
  • Events
  • Research
  • Contact
SUBSCRIBE
No Result
View All Result
Health & Protection
  • PMI & Healthcare
    • Individual
    • SME
    • Large Corporate
    • Cash Plans
    • Hospitals
  • Protection
    • Group Risk
    • Individual Protection
  • International
  • Wellbeing & Mental Health
    • Absence/Productivity
    • Mental Health
    • Services
  • Appointments / Industry
    • Appointments
    • Company News
    • Compliance & Regulation
    • Economy
Health & Protection
No Result
View All Result

Consumer Duty did not explicitly ban loaded premiums, but it may as well have – Müdd

by Tony Müdd, divisional director of St James’s Place

by admin
08 August 2022
Consumer Duty does not give wriggle room on loaded premiums – Müdd
Share on FacebookShare on Twitter

I have heard the Financial Conduct Authority’s (FCA) Consumer Duty described in many ways.

This ranges from “unnecessary meddling”, to which I do not subscribe, to the “Retail Distribution Review mark II on speed”, to which I am more inclined to lean.

It hasn’t been explicitly stated and the FCA is hardly likely to do so, but you have to draw the conclusion that the very existence of Consumer Duty is down to the failure of legislation, guidance and enforcement orders that have gone before it.

We would all, almost certainly, have different views as to whom is to blame for this failure but we all have to take collective responsibility – by which I do mean all: manufacturers, distributors and regulators.

It has to be different this time.

And it was in this frame of mind I sat down in a darkened room with a cold towel over my head to read FG22/5.

For those who have yet to have this pleasure it is the FCA’s Final non-handbook guidance for firms on the Consumer Duty.

At 121 riveting pages I couldn’t do justice to a summary of it here but I was drawn to certain sections.

I wanted to see how far the ability for manufacturers and distributors to interpret the guidance extended to those areas that represented the poorest practices and worse excesses.

 

Eureka moment

Working my way through the document, which is a dichotomy of comprehensive repetitive information with a distinct lack of detail, revealed numerous hints along the way.

But nothing concrete. Nothing that gave me that eureka moment.

That is until I got to Chapter 7: The price and value outcome.

It starts well at 7.1: “Retail customers experience harm where they don’t get value for money” – a clear opening gambit.

Then at 7.3: “…value needs to be considered in the round and low prices do not always mean fair value. We expect firms to think about price when assessing fair value but not at the expense of other factors”.

Again this is fair, although I doubt the FCA had higher levels of commission in mind when referencing other factors.

In 7.8 the document states: “…the price and value outcome rules should prompt questions such as: Are there fees or charges or rates which appear unjustifiably or unreasonably high compared to other comparable products (either in the firm’s product portfolio or comparable products supplied by other firms)?”

That would be yes. There are similar references along these lines in 7.10, 7.15 and 7.19.

 

Hitting home for manufacturers

Moving on to a sub section within the chapter titled The price charged to consumers, the first paragraph 7.25 states: “When considering price manufacturers must consider: where different distribution arrangements result in different prices for consumers manufacturers must ensure that distribution arrangements do not cause the product to become unfair value”.

Good luck with that one.

To really hit this message home for manufacturers in 7.35 it is confirmed: “Where a manufacturer sets the price, including distribution charges (i.e. through commissions) then they are responsible for ensuring that the product provides fair value.”

Chapter 7 ends with a summary of actions in 7.56 that are either consistent or inconsistent with the duty.

I cannot decide which of the examples of inconsistent actions listed are my favourite but have narrowed it down to: “A firm has products with different charges/fees/prices but with similar levels of benefit” or “A firm has a product that is priced based on risk… but one group pays costs that are disproportionate to the benefit received”.

As the headline of this pieces says, the Consumer Duty hasn’t explicitly banned loaded premiums but based upon my and any rationale person’s reading of FG22/5, it may as well have done.

 

Next Post
Legal & General CEO Wilson ‘delighted’ with knighthood

Legal & General protection sales drop 19% as shrinking market prediction hits

Employers not fully grasping workplace absence during pandemic – Howden

Herbert warns employers not to ride out recession by axing workplace benefits

Allianz Life North America CEO joins Blue Cross and Blue Shield board of trustees

Allianz Life North America CEO joins Blue Cross and Blue Shield board of trustees

HAVE YOU READ?

UK Health & Protection Awards 2025 provider shortlists revealed

UK Health & Protection Awards 2025: The keys to submitting a great adviser entry

9 May 2025

Read more
UK Health & Protection Awards 2025 provider shortlists revealed

UK Health & Protection Awards 2025 provider shortlists revealed

8 May 2025

Read more
Health & Protection

© 2025 Definite Article Limited. Design by 71 Media Limited.

  • About
  • Advertise
  • Privacy policy
  • Terms & Conditions
  • Contact

Follow Healthcare & Protection

X
No Result
View All Result
  • PMI & Healthcare
    • Individual
    • SME
    • Large Corporate
    • Cash Plans
    • Hospitals
  • Protection
    • Group Risk
    • Individual Protection
  • International
  • Wellbeing & Mental Health
    • Absence/Productivity
    • Mental Health
    • Services
  • Appointments / Industry
    • Appointments
    • Company News
    • Compliance & Regulation
    • Economy

No Result
View All Result
  • PMI & Healthcare
    • Individual
    • SME
    • Large Corporate
    • Cash Plans
    • Hospitals
  • Protection
    • Group Risk
    • Individual Protection
  • International
  • Wellbeing & Mental Health
    • Absence/Productivity
    • Mental Health
    • Services
  • Appointments / Industry
    • Appointments
    • Company News
    • Compliance & Regulation
    • Economy